iBio, Inc.

NASDAQ:IBIO

Biotechnology

Healthcare
$0.80 +0.00%

+$0.00 today

Market cap
$56.44M
Beta
1.29
P/E (TTM)
-3.6
EPS (TTM)
-$0.32
52W Low $0.78High $3.82

Volume 0.43M

Average 0.81M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$23.22M

FY 2026 · Annual

Investing Cash Flow

-$32.00M

FY 2026 · Annual

Financing Cash Flow

$103.05M

FY 2026 · Annual

+1054.1% YoY

Cash Flow Statement

USD
Metric
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
FY2026
Jun 2026
Net Income(29.51M)(65.01M)(24.91M)(18.38M)(33.04M)
Depreciation & Amortization3.79M1.38M1.25M291K88K
Deferred Income Tax00000
Stock-Based Compensation4.38M4.39M2.04M1.53M1.37M
Change in Working Capital3.24M5.87M(3.17M)479K2.52M
Accounts Receivables4.21M6.1M00(65K)
Inventory(3.87M)(1.02M)000
Accounts Payables1.24M(625K)(1.49M)1.83M2.22M
Other Working Capital1.66M1.41M(1.68M)(1.35M)364K
Other Non-Cash Items(15.32M)22.93M6.23M773K5.84M
Operating Cash Flow(37.8M)(30.44M)(18.55M)(15.3M)(23.22M)
Capital Expenditures(7.33M)(5.74M)(210K)(16K)(578K)
Acquisitions (Net)0(692K)000
Purchases of Investments(7.12M)000(42.3M)
Sales of Investments13.62M10.84M000
Other Investing Activities(4.3M)2.6M1.12M758K10.88M
Investing Cash Flow(5.13M)7.01M906K742K(32M)
Debt Repayment(5.83M)(9.13M)(1.14M)(771K)(6.63M)
Common Stock Issued77K11.49M25.52M9.7M109.58M
Common Stock Repurchased0(39K)(7K)00
Dividends Paid00000
Other Financing Activities(50K)(22K)197K0105K
Financing Cash Flow(5.8M)2.3M24.49M8.93M103.05M
Effect of Forex Changes(6M)33K00(18K)
Net Change in Cash(54.73M)(21.09M)6.85M(5.63M)47.83M
Free Cash Flow(45.13M)(36.17M)(18.76M)(15.32M)(23.8M)

Free Cash Flow

Net Income to FCF bridge

FY2026

= Net Income-$33.0M
+ D&A$88.0K
+ Stock-Based Comp$1.4M
+ Deferred Tax$0
+ Working Capital$2.5M
+ Other Non-Cash$5.8M
= Operating Cash Flow-$23.2M
- Capex-$578.0K
= Free Cash Flow-$23.8M

Analysis

FY2026 free cash flow is -$23.8M. FCF conversion is 72.0% of net income. Operating cash flow was -$23.2M, with capex of -$578.0K. The largest bridge item is Other Non-Cash at $5.8M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 10, 2026
10-QQuarterly reportNov 10, 2026
8-KCurrent reportOct 19, 2026
4Statement of changes in beneficial ownershipOct 15, 2026
4Statement of changes in beneficial ownershipOct 15, 2026

Does IBIO generate free cash flow?

iBio, Inc. (IBIO) generated -$23.80M of free cash flow in fiscal 2026.

How much operating cash flow does IBIO produce?

Operating cash flow was -$23.22M, before capital expenditures of $578,000.00.